(Q60697885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

title

Phase I trial of docetaxel, oxaliplatin, and capecitabine (DOC) in untreated gastric cancer patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

main subject

phase I clinical trial

1 reference

1 reference

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gianmaria Miolo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Giovanni Lo Re

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Giuseppe Toffoli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

author name string

Sergio Frustaci

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Elisa Turchet

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Giuseppe Corona

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Gianna Tabaro

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Elena Torrisi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

Salvatore Tumolo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

publication date

5 June 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Clinical Oncology

3 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

page(s)

510-516

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

A Phase I Study Of Docetaxel, Oxaliplatin, & Capecitabine (DOC) As First-Line Therapy of Patients With Locally Advanced or Metastatic Adenocarcinoma of Stomach and GE Junction

3 February 2020

cites work

1 reference

12 December 2020

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group

1 reference

12 December 2020

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

1 reference

12 December 2020

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research

1 reference

12 December 2020

A systematic overview of chemotherapy effects in gastric cancer

1 reference

12 December 2020

A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours

1 reference

12 December 2020

Randomised comparison of fluorouracil, epidoxorubicin and methotrexate (FEMTX) plus supportive care with supportive care alone in patients with non-resectable gastric cancer

1 reference

12 December 2020

Epidemiology of gastric cancer

1 reference

12 December 2020

A phase I study of docetaxel, oxaliplatin, and capecitabine in patients with metastatic gastroesophageal cancer

1 reference

12 December 2020

High-throughput plasma docetaxel quantification by liquid chromatography-tandem mass spectrometry

1 reference

12 December 2020

Modified therapy with 5-fluorouracil, doxorubicin, and methotrexate in advanced gastric cancer

1 reference

12 December 2020

Short-time infusion of oxaliplatin (Eloxatin) in combination with capecitabine (Xeloda) in patients with advanced colorectal cancer

1 reference

12 December 2020

Induction of thymidine phosphorylase activity and enhancement of capecitabine efficacy by taxol/taxotere in human cancer xenografts.

1 reference

12 December 2020

Survival of patients with oesophageal and gastric cancers in Europe

1 reference

12 December 2020

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer.

1 reference

12 December 2020

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

1 reference

12 December 2020

Phase I study of docetaxel, oxaliplatin and capecitabine (TEX) as first line therapy to patients with advanced gastro-oesophageal cancer.

1 reference

12 December 2020

10.1007/S10147-012-0410-Z

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22669361%20AND%20SRC:MED&resulttype=core&format=json

3 February 2020

1 reference